Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Melatonin In Acute Mania Investigation (MIAMI-UK). A randomized controlled trial of add-on melatonin in bipolar disorder.

Quested DJ. et al, (2020), Bipolar Disord

Effects of typhoid vaccine on inflammation and sleep in healthy participants: a double-blind, placebo-controlled, crossover study.

Sharpley AL. et al, (2016), Psychopharmacology (Berl), 233, 3429 - 3435

Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing.

Masaki C. et al, (2016), Psychopharmacology (Berl), 233, 2655 - 2661

Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans.

Singh N. et al, (2016), Neuropsychopharmacology, 41, 1768 - 1778

Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla.

Masaki C. et al, (2016), Psychopharmacology (Berl), 233, 1097 - 1104

Pharmacotherapies for sleep disturbances in Alzheimer's disease

McCleery J. et al, (2015), BJ Psych Advances, 21

Pharmacotherapies for sleep disturbances in Alzheimer's disease.

McCleery J. et al, (2014), Cochrane Database Syst Rev

Folic acid supplementation for prevention of mood disorders in young people at familial risk: a randomised, double blind, placebo controlled trial.

Sharpley AL. et al, (2014), J Affect Disord, 167, 306 - 311

In response to "The effect of agomelatine on 5HT(2C) receptors in humans: a clinically relevant mechanism?" by Trevor Norman.

Sharpley AL. and Cowen PJ., (2012), Psychopharmacology (Berl), 221

In response to "the effect of agomelatine on 5HT 2C receptors in humans: A clinically relevant mechanism?" by Trevor Norman

Sharpley AL. and Cowen PJ., (2012), Psychopharmacology, 221

Does agomelatine block 5-HT2C receptors in humans?

Sharpley AL. et al, (2011), Psychopharmacology (Berl), 213, 653 - 655

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.

Wilson SJ. et al, (2010), J Psychopharmacol, 24, 1577 - 1601

An open trial of cognitive therapy for chronic insomnia.

Harvey AG. et al, (2007), Behav Res Ther, 45, 2491 - 2501

Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.

Sharpley AL. et al, (2005), J Clin Psychiatry, 66, 450 - 454

Olanzapine increases slow wave sleep in SSRI resistant depressed patients

Sharpley AL. et al, (2004), JOURNAL OF PSYCHOPHARMACOLOGY, 18, A14 - A14

Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients.

Sharpley AL. et al, (2003), J Clin Psychiatry, 64, 192 - 196

The effect of Li 1370, extract of Ginkgo biloba, on REM sleep in humans.

Murray BJ. et al, (2001), Pharmacopsychiatry, 34, 155 - 157

Decreased tryptophan availability but normal post-synaptic 5-HT2c receptor sensitivity in chronic fatigue syndrome.

Vassallo CM. et al, (2001), Psychol Med, 31, 585 - 591

Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine.

Sharpley AL. et al, (2001), Psychopharmacology (Berl), 153, 271 - 272

Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.

Sharpley AL. et al, (2000), Biol Psychiatry, 47, 468 - 470

Load More

Include forthcoming?